changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
Certain BTG products may not be available within the chosen location and indications may differ from your country's approved use.
For Medical questions regarding any BTG products, please contact firstname.lastname@example.org
17 Dec 2015
After being vindicated in her 2014 purchase of a U.S. company with a device to prop open diseased lungs, the chief executive of British healthcare group BTG (BTG.L) is scouring the horizon for the next promising acquisition.
29 Sep 2015
The recent New York Times article on Amazon's "bruising workplace" sparked a firestorm of reaction.
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has received additional approval for the vascular embolization device DC Bead® (specially controlled medical device, “DC Bead”) to be used for the treatment of hypervascular tumors and arteriovenous malformations (AVM) in Japan.
5 Sep 2015
BILLINGS – Millions of tiny glass beads have given some liver cancer patients in Billings another option in their fight against the disease.
28 Apr 2015
Cancer treatment with radioactive glass microspheres is to be trialled for the first time in the UK at Oxford's Churchill Hospital.
22 Apr 2015
Banner - University Medical Center Phoenix has been named the West Coast Center of Excellence for TheraSphere®, a microsphere liver cancer treatment. The Phoenix hospital is one of only three locations in the United States to earn the prestigious recognition for radioembolization procedures and will be a training site for physicians throughout the country.
13 Feb 2015
DVT: Fixing Clots, Saving Lives